Clinical Trials Directory

Trials / Completed

CompletedNCT05281432

Balance in Individuals With Pes Planus

Evaluation of Balance in Individuals Diagnosed With Pes Planus

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Istanbul Medipol University Hospital · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers

Summary

Pes planus, one of the most common biomechanical disorders in the lower extremities, negatively affects the daily life of the individual and their competence in activities. The aim of this study was to evaluate the static and dynamic balance status of male individuals diagnosed with pes planus.

Detailed description

METHODS: 22 volunteer patients diagnosed with pes planus in Medipol Mega University Hospital Physical Therapy and Rehabilitation Clinic will be included in the study. This study was approved by Medipol University Non-Interventional Clinical Research Ethics Committee at the meeting numbered 10840098-604.01.01-E.63688 with decision number 1027. approved. The signatures of the participants included in the study were given with the "Informed Voluntary Consent Form". Oral and written about the research. With the "Participant Diagnosis Form", the person's name-surname, age, gender, height, weight, body mass index, contact number, Pes Planus degree, whether he has a diagnosed disease, whether he has a past disability or whether he has had surgery will be questioned. . In the 30-45 age group, 22 volunteers with pes planus and 24 volunteers without pes planus will be included in the study. Individuals in the pes planus group will be formed at the 2nd and 3rd levels by a single physiotherapist with clinical experience, based on the Feiss line in pes planus.

Conditions

Timeline

Start date
2019-04-12
Primary completion
2021-05-25
Completion
2022-02-20
First posted
2022-03-16
Last updated
2022-03-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05281432. Inclusion in this directory is not an endorsement.